Antineoplastics/granulocyte colony-stimulating factor/granulocyte-macrophage colony-stimulating factorPneumonitis: 5 case reports

被引：0
作者：
机构：
来源：
Reactions Weekly | 1999年 / 742卷 / 1期
关键词：
Doxorubicin; Methotrexate; Pleural Effusion; Methylprednisolone; Bleomycin;
D O I：
10.2165/00128415-199907420-00013
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [41] The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma
    Erkisi, M
    Erkurt, E
    Ozbarlas, S
    Burgut, R
    Doran, F
    Seyrek, E
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (03) : 224 - 228
  • [42] PHASE-I STUDY OF DOXORUBICIN, ICRF-187 AND GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR
    WALSH, C
    BLUM, RH
    ORATZ, R
    GOLDENBERG, A
    DOWNEY, A
    SPEYER, JL
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (01) : 61 - 66
  • [43] Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, Hongki
    Park, Seon Young
    Shin, Juhee
    Han, Hye Sug
    Suh, Young Jin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (02) : 59 - 66
  • [44] Infusional chemotherapy combined with recombinant human granulocyte colony stimulating factor - Advantages and limitations
    Weiss, AJ
    Lackman, RD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 63 - 68
  • [45] THE USE OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR WITH COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED ADULT SOFT-TISSUE SARCOMAS - EARLY RESULTS FROM THE EORTC SOFT-TISSUE AND BONE SARCOMA GROUP
    STEWARD, WP
    VERWEIJ, J
    SOMERS, R
    SPOONER, D
    KERBRAT, P
    CLAVEL, M
    CROWTHER, D
    ROUESSE, J
    TURSZ, T
    TUENI, E
    VANOOSTEROM, AT
    VANGLABBEKE, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 31 : S241 - S244
  • [46] Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease
    Aglietta, M
    Montemurro, F
    Fagioli, F
    Volta, C
    Botto, B
    Cantonetti, M
    Racanelli, V
    Teofili, L
    Ferrara, R
    Amadori, S
    Castoldi, GL
    Dammacco, F
    Levis, A
    CANCER, 2000, 88 (02) : 454 - 460
  • [47] Adjuvant Docetaxel and Cyclophosphamide (DC) with Prophylactic Granulocyte Colony-Stimulating Factor (G-CSF) on Days 8 & 12 in Breast Cancer Patients: A Retrospective Analysis
    Yerushalmi, Rinat
    Goldvaser, Hadar
    Sulkes, Aaron
    Ben-Aharon, Irit
    Hendler, Daniel
    Neiman, Victoria
    Ciuraru, Noa Beatrice
    Bonilla, Luisa
    Amit, Limor
    Zer, Alona
    Granot, Tal
    Rizel, Shulamith
    Stemmer, Salomon M.
    PLOS ONE, 2014, 9 (10):
  • [48] Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis
    Baran, Christopher P.
    Opalek, Judy M.
    McMaken, Sara
    Newland, Christie A.
    O'Brien, James M., Jr.
    Hunter, Melissa G.
    Bringardner, Benjamin D.
    Monick, Martha M.
    Brigstock, David R.
    Stromberg, Paul C.
    Hunninghake, Gary W.
    Marsh, Clay B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (01) : 78 - 89
  • [49] Effects of granulocyte colony-stimulating factor on the kinetics of inflammatory cells in the peripheral blood and pulmonary lesions during the development of bleomycin-induced lung injury in rats
    Adachi, K
    Suzuki, M
    Sugimoto, T
    Uetsuka, K
    Nakamaya, H
    Doi, K
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2003, 55 (01) : 21 - 32
  • [50] Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy
    Choi, Jae Hee
    Geum, Min Jung
    Kang, Ji Eun
    Park, Nam Gi
    Oh, Yun Kyoung
    Rhie, Sandy Jeong
    PHARMACEUTICALS, 2021, 14 (11)
12345